Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 7.70
  • 52 Week Low: 2.65
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 31,918
  • Market Cap: £285.99m
  • RiskGrade: 268

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

Allergy Therapeutics confident in funding as results remain late

By Josh White

Date: Friday 20 Jan 2023

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.

Allergy Therapeutics pauses production at Freeman facility

By Josh White

Date: Tuesday 04 Oct 2022

(Sharecast News) - Biotechnology company Allergy Therapeutics has "proactively paused" production at the Freeman facility, part of its Worthing manufacturing site, to accelerate ongoing site improvements, it announced on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 6.00p
Change Today -0.25p
% Change -4.00 %
52 Week High 7.70
52 Week Low 2.65
Volume 31,918
Shares Issued 4,766.44m
Market Cap £285.99m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.02% below the market average67.02% below the market average67.02% below the market average67.02% below the market average67.02% below the market average
58.33% below the sector average58.33% below the sector average58.33% below the sector average58.33% below the sector average58.33% below the sector average
Price Trend
81.25% above the market average81.25% above the market average81.25% above the market average81.25% above the market average81.25% above the market average
79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average
Income Not Available
Growth
53.97% below the market average53.97% below the market average53.97% below the market average53.97% below the market average53.97% below the market average
61.29% below the sector average61.29% below the sector average61.29% below the sector average61.29% below the sector average61.29% below the sector average

AGY Dividends

No dividends found

Trades for 04-Apr-2025

Time Volume / Share Price
11:47 12,500 @ 5.82p
10:34 10,000 @ 6.00p
09:26 1,070 @ 6.00p
09:26 25 @ 6.50p
09:00 3,001 @ 6.45p

AGY Key Personnel

CEO Manuel Llobet

Top of Page